Switzerland as a medical technology hub: the key points at a glance

Switzerland as a medical technology hub: the key points at a glance
CT scanner

Switzerland holds a leading position worldwide in the medical technology sector. Medical technology does not make as significant a contribution to the gross domestic product in any other country in the world than it does in Switzerland. Switzerland is also in first place, ahead of Germany and the UK in terms of the percentage of medical technology employees as a portion of the entire working population. Switzerland is an extremely attractive location for research, development, and production in the medical technology sector with first-class research institutions, expertise in precision technologies, and a sophisticated healthcare system requiring suitable products. 

The productivity of the Swiss Life Sciences industry is unrivalled compared with other top locations such as Boston, Öresund, the San Francisco Bay Area, New York, or Paris. Each year, 286,000 US dollars are generated here per employee. 60,000 US dollars more than in New York. 

Switzerland also holds a leading position when it comes to capital procurement. It represents by far the most important stock exchange for Life Sciences companies in Europe. Around a third of market capitalization on the SIX Swiss Exchange is attributable to Life Sciences companies. 42% of the market capital of European Life Sciences companies is listed on the SIX.

Download Medical Technology fact sheet

Global,

Switzerland holds a leading position worldwide in the medical technology sector. Medical technology does not make as significant a contribution to the gross domestic product in any other country in the world than it does in Switzerland. Switzerland is also in first place, ahead of Germany and the UK in terms of the percentage of medical technology employees as a portion of the entire working population. Switzerland is an extremely attractive location for research, development, and production in the medical technology sector with first-class research institutions, expertise in precision technologies, and a sophisticated healthcare system requiring suitable products. 

The productivity of the Swiss Life Sciences industry is unrivalled compared with other top locations such as Boston, Öresund, the San Francisco Bay Area, New York, or Paris. Each year, 286,000 US dollars are generated here per employee. 60,000 US dollars more than in New York. 

Switzerland also holds a leading position when it comes to capital procurement. It represents by far the most important stock exchange for Life Sciences companies in Europe. Around a third of market capitalization on the SIX Swiss Exchange is attributable to Life Sciences companies. 42% of the market capital of European Life Sciences companies is listed on the SIX.

Download Medical Technology fact sheet

Downloads 
Page Meta 
Fact Sheet

Explore Leading Companies - Biotech